UBS Remains a Hold on Chemours Company (CC)
UBS analyst John Roberts maintained a Hold rating on Chemours Company (CC) today and set a price target of $14.50. The company’s shares closed last Monday at $13.98, close to its 52-week low of $11.71.
According to TipRanks.com, Roberts is a 2-star analyst with an average return of -0.2% and a 62.3% success rate. Roberts covers the Consumer Goods sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and DuPont de Nemours, Inc.
Currently, the analyst consensus on Chemours Company is a Moderate Buy with an average price target of $16.64.
See today’s analyst top recommended stocks >>
Chemours Company’s market cap is currently $2.29B and has a P/E ratio of 4.06. The company has a Price to Book ratio of 2.78.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts, Chemical Solutions, and Corporate and Other. The Titanium Technologies segment produces titanium dioxide.